[go: up one dir, main page]

AR003923A1 - Mmedicamento que contiene, en combinacion, uno o mas inhibidores de proteasa y uno o mas derivados de quinoxalinas - Google Patents

Mmedicamento que contiene, en combinacion, uno o mas inhibidores de proteasa y uno o mas derivados de quinoxalinas

Info

Publication number
AR003923A1
AR003923A1 ARP960101379A AR10137996A AR003923A1 AR 003923 A1 AR003923 A1 AR 003923A1 AR P960101379 A ARP960101379 A AR P960101379A AR 10137996 A AR10137996 A AR 10137996A AR 003923 A1 AR003923 A1 AR 003923A1
Authority
AR
Argentina
Prior art keywords
combination
protease inhibitors
product containing
medicinal product
quinoxalin derivatives
Prior art date
Application number
ARP960101379A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR003923A1 publication Critical patent/AR003923A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Medicamento que contiene, en combinación, uno o más inhibidores de proteasa y uno o más derivados de quinoxalinas que comprenden la fórmula general (I) y(Ia), así como sus formas tantómeras de fórmula (Ia), donde los sustituyentes se definen en lamemoria descriptiva.
ARP960101379A 1995-02-27 1996-02-14 Mmedicamento que contiene, en combinacion, uno o mas inhibidores de proteasa y uno o mas derivados de quinoxalinas AR003923A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19506742A DE19506742A1 (de) 1995-02-27 1995-02-27 Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Publications (1)

Publication Number Publication Date
AR003923A1 true AR003923A1 (es) 1998-09-30

Family

ID=7755115

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101379A AR003923A1 (es) 1995-02-27 1996-02-14 Mmedicamento que contiene, en combinacion, uno o mas inhibidores de proteasa y uno o mas derivados de quinoxalinas

Country Status (19)

Country Link
EP (1) EP0728481A3 (es)
JP (1) JPH08245392A (es)
KR (1) KR960030951A (es)
CN (1) CN1141196A (es)
AR (1) AR003923A1 (es)
AU (1) AU710158B2 (es)
BR (1) BR9600809A (es)
CA (1) CA2170222A1 (es)
CZ (1) CZ57896A3 (es)
DE (1) DE19506742A1 (es)
FI (1) FI960850A7 (es)
HR (1) HRP960070A2 (es)
HU (1) HUP9600455A3 (es)
IL (1) IL117247A (es)
NO (1) NO960775L (es)
NZ (1) NZ286058A (es)
PL (1) PL312908A1 (es)
SK (1) SK25196A3 (es)
ZA (1) ZA961516B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716760B2 (en) * 1996-11-08 2000-03-09 Japan Energy Corporation Aids therapeutic composition
DE19703131A1 (de) * 1997-01-29 1998-07-30 Bayer Ag Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
US6235740B1 (en) 1997-08-25 2001-05-22 Bristol-Myers Squibb Co. Imidazoquinoxaline protein tyrosine kinase inhibitors
US6635626B1 (en) 1997-08-25 2003-10-21 Bristol-Myers Squibb Co. Imidazoquinoxaline protein tyrosine kinase inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
EP1066286B1 (en) * 1998-03-04 2009-04-29 Bristol-Myers Squibb Company Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
DE10013318A1 (de) * 2000-03-17 2001-09-20 Merck Patent Gmbh Formulierung enthaltend Chinoxalinderivate
US7094807B2 (en) 2002-11-19 2006-08-22 Achillion Pharmaceuticals, Inc. Substituted aryl thioureas and related compounds; inhibitors of viral replication
TW200600492A (en) 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
CN105229002A (zh) * 2012-12-20 2016-01-06 拜耳医药股份有限公司 抑制bet蛋白的二氢吡啶并吡嗪酮
DE102017005089A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one
DE102017005091A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE205837T1 (de) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
CN1141196A (zh) 1997-01-29
AU710158B2 (en) 1999-09-16
AU4561596A (en) 1996-09-05
FI960850L (fi) 1996-08-28
NO960775D0 (no) 1996-02-26
PL312908A1 (en) 1996-09-02
CZ57896A3 (en) 1996-09-11
HUP9600455A2 (en) 1996-12-30
HRP960070A2 (en) 1997-10-31
KR960030951A (ko) 1996-09-17
SK25196A3 (en) 1997-05-07
EP0728481A3 (de) 1998-07-08
IL117247A (en) 2000-10-31
FI960850A7 (fi) 1996-08-28
NO960775L (no) 1996-08-28
HU9600455D0 (en) 1996-04-29
BR9600809A (pt) 1997-12-23
NZ286058A (en) 1998-09-24
ZA961516B (en) 1996-09-03
HUP9600455A3 (en) 1998-04-28
FI960850A0 (fi) 1996-02-23
IL117247A0 (en) 1996-06-18
EP0728481A2 (de) 1996-08-28
DE19506742A1 (de) 1996-08-29
JPH08245392A (ja) 1996-09-24
CA2170222A1 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
AR003923A1 (es) Mmedicamento que contiene, en combinacion, uno o mas inhibidores de proteasa y uno o mas derivados de quinoxalinas
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
DK0833839T3 (da) Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
AR011069A1 (es) Compuestos amidino, proceso para su preparacion, compuestos intermediarios, formulaciones farmaceuticas que los comprenden, y su uso en la fabricacion de un medicamento como inhibidor de la oxido nitrico sintasa inducible.
DE50210313D1 (de) Amphotere sterole und deren verwendung
MX9700557A (es) Dihidrobenzofuranos.
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
DE3687365D1 (de) N-acylpyrrolidin-derivate, verfahren zur herstellung, heilmittel, die sie enthalten und ihre anwendung.
TR200200795T2 (tr) 5-HT1B antagonistleri olarak piperazin türevleri
BR9801652A (pt) Resorcinil-triazinas
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
DK1193270T3 (da) Pyrrolobenzodiazepiner
ES2146297T3 (es) Nuevos derivados del benzopirano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
KR960705815A (ko) 신규한 피라진 카복스아미드 유도체, 이의 제조방법 및 약제에 있어서의 이의 용도(Novel pyrazine carboxamide derivatives, their production and their use in medicaments)
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO934628L (no) Retrovirus-protease-inhibitorer
AR011094A1 (es) Medicamento que contiene quinoxalinas en triple combinacion y el uso de quinoxalinas en triple combinacion con inhibidores de proteasas e inhibidoresde transcriptasa como medicamento para el tratamiento del sida y/o de infecciones por hiv
AR016973A1 (es) Uso de aminometil-cromanos sustituidos para la produccion de un medicamento util para el tratamiento de enfermedades neurodegenerativas y para el estimulode la regeneracion neuronal
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.

Legal Events

Date Code Title Description
FB Suspension of granting procedure